Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications), By Region and By Country for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. During the forecast period, 2024-2029, the Global Antibiotic Drugs market is expected to grow at a CAGR of 4.7%
The Global Antibiotic Drugs Market is expected to generate USD 73.92 Billion by the end of 2029, up from USD 50.41 Billion in 2022. The antibiotic drugs market has witnessed steady growth over the years. The increasing prevalence of bacterial infections, coupled with the perpetual evolution of antibiotic resistance, propels the demand for innovative antibiotic therapies. The market is characterized by a diverse range of antibiotics, including Cephalosporins, fluoroquinolones, macrolides, and tetracyclines, each playing a distinct role in addressing bacterial infections.
The increased recognition of the significance of prompt and efficient antibiotic treatment within the healthcare community and the general populace catalyse increased demand. Programs advocating for responsible antibiotic usage and providing education about the repercussions of antibiotic resistance play a crucial role in influencing market trends. The escalating threat of antibiotic resistance has prompted concerted global efforts to develop new antibiotics and preserve the effectiveness of existing ones. Collaborative initiatives between pharmaceutical companies, research institutions, and governmental bodies aim to address this critical healthcare challenge.
Scope of the Report
• The report analyses the Antibiotic Drugs Market by Value (USD Billion).
• The report presents the analysis of the Antibiotic Drugs Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Antibiotic Drugs Market by Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Other Drug Classes).
• The report analyses the Antibiotic Drugs Market By Spectrum (Broad Spectrum, Narrow Spectrum)
• The report analyses the Antibiotic Drugs Market By Indication (Pneumonia, Meningitis, Gastrointestinal infections, Urinary Tract Infections, Other Indications).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Drug Class, By Spectrum & By Indication.
• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Abbott Laboratories, Johnson & Johnson, Pfizer, GSK PLC, Novartis AG, Roche Holding AG, Bayer AG, Merck & Co., Inc., Viatris Inc. and Cipla.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
3. Global Antibiotic Drugs Market: Historic and Forecast (2019-2029)
3.1 Global Prevalence of Infectious Diseases, 2019
3.2 Global Incidence of Infectious Diseases, 2019
3.3 Top 10 most prescribed outpatient antibiotics
3.4 Global Antibiotic Drugs Market: Dashboard
3.5 Global Antibiotic Drugs Market: Market Value Assessment, 2019-2029 (USD Billion)
3.6 Impact of COVID-19 on Global Antibiotic Drugs Market
3.7 Global Antibiotic Drugs Market Segmentation: By Drug Class
3.7.1 Global Antibiotic Drugs Market, By Drug Class Overview
3.7.2 Global Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.3 Global Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.4 Global Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.5 Global Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.6 Global Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
3.8 Global Antibiotic Drugs Market Segmentation: By Spectrum
3.8.1 Global Antibiotic Drugs Market, By Spectrum Overview
3.8.2 Global Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.3 Global Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
3.9 Global Antibiotic Drugs Market Segmentation: By Indication
3.9.1 Global Antibiotic Drugs Market, By Indication Overview
3.9.2 Global Antibiotic Drugs Market Size, By Pneumonia By Value, 2019H-2029F (USD Billion & CAGR)
3.9.3 Global Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.4 Global Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.5 Global Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
3.9.6 Global Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
4. Global Antibiotic Drugs Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Antibiotic Drugs Market: Historic and Forecast (2019-2029)
5.1 Americas Antibiotic Drugs Market: Snapshot
5.2 Americas Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Antibiotic Drugs Market: Key Factors
5.4 Americas Antibiotic Drugs Market: Segment Analysis
5.5 Americas Antibiotic Drugs Market Segmentation: By Drug Class
5.5.1 Americas Antibiotic Drugs Market, By Drug Class Overview
5.5.2 Americas Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.6 Americas Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Antibiotic Drugs Market Segmentation: By Spectrum
5.6.1 Americas Antibiotic Drugs Market, By Spectrum Overview
5.6.2 Americas Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
5.6.3 Americas Antibiotic Drugs Market Size, By Narrow spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
5.7 Americas Antibiotic Drugs Market Segmentation: By Indication
5.7.1 Americas Antibiotic Drugs Market, By Indication Overview
5.7.2 Americas Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
5.7.3 Americas Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
5.7.4 Americas Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
5.7.5 Americas Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
5.7.6 Americas Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
5.8 Americas Antibiotic Drugs Market Segmentation: By Country
5.8.1 United States Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.8.1.1 United States Antibiotic Drugs Market, By Drug Class
5.8.1.2 United States Antibiotic Drugs Market, By Spectrum
5.8.1.3 United States Antibiotic Drugs Market, By Indication
5.8.2 Canada Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.8.2.1 Canada Antibiotic Drugs Market, By Drug Class
5.8.2.2 Canada Antibiotic Drugs Market, By Spectrum
5.8.2.3 Canada Antibiotic Drugs Market, By Indication
5.8.3 Rest of Americas Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.8.3.1 Rest of Americas Antibiotic Drugs Market, By Drug Class
5.8.3.2 Rest of Americas Antibiotic Drugs Market, By Spectrum
5.8.3.3 Rest of Americas Antibiotic Drugs Market, By Indication
6. Europe Antibiotic Drugs Market: Historic and Forecast (2019-2029)
6.1 Europe Antibiotic Drugs Market: Snapshot
6.2 Europe Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Antibiotic Drugs Market: Key Factors
6.4 Europe Antibiotic Drugs Market: Segment Analysis
6.5 Europe Antibiotic Drugs Market Segmentation: By Drug Class
6.5.1 Europe Antibiotic Drugs Market, By Drug Class Overview
6.5.2 Europe Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.5 Europe Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.6 Europe Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Antibiotic Drugs Market Segmentation: By Spectrum
6.6.1 Europe Antibiotic Drugs Market, By Spectrum Overview
6.6.2 Europe Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
6.6.3 Europe Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
6.7 Europe Antibiotic Drugs Market Segmentation: By Indication
6.7.1 Europe Antibiotic Drugs Market, By Indication Overview
6.7.2 Europe Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
6.7.3 Europe Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
6.7.4 Europe Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
6.7.5 Europe Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
6.7.6 Europe Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
6.8 Europe Antibiotic Drugs Market Segmentation: By Country
6.8.1 Germany Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.8.1.1 Germany Antibiotic Drugs Market, By Drug Class
6.8.1.2 Germany Antibiotic Drugs Market, By Spectrum
6.8.1.3 Germany Antibiotic Drugs Market, By Indication
6.8.2 United Kingdom Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.8.2.1 United Kingdom Antibiotic Drugs Market, By Drug Class
6.8.2.2 United Kingdom Antibiotic Drugs Market, By Spectrum
6.8.2.3 United Kingdom Antibiotic Drugs Market, By Indication
6.8.3 France Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.8.3.1 France Antibiotic Drugs Market, By Drug Class
6.8.3.2 France Antibiotic Drugs Market, By Spectrum
6.8.3.3 France Antibiotic Drugs Market, By Indication
6.8.4 Italy Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.8.4.1 Italy Antibiotic Drugs Market, By Drug Class
6.8.4.2 Italy Antibiotic Drugs Market, By Spectrum
6.8.4.3 Italy Antibiotic Drugs Market, By Indication
6.8.5 Spain Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.8.5.1 Spain Antibiotic Drugs Market, By Drug Class
6.8.5.2 Spain Antibiotic Drugs Market, By Spectrum
6.8.5.3 Spain Antibiotic Drugs Market, By Indication
6.8.6 Rest of Europe Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.8.6.1 Rest of Europe Antibiotic Drugs Market, By Drug Class
6.8.6.2 Rest of Europe Antibiotic Drugs Market, By Spectrum
6.8.6.3 Rest of Europe Antibiotic Drugs Market, By Indication
7. Asia-Pacific Antibiotic Drugs Market: Historic and Forecast (2019-2029)
7.1 Asia-Pacific Antibiotic Drugs Market: Snapshot
7.2 Asia-Pacific Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia-Pacific Antibiotic Drugs Market: Key Factors
7.4 Asia-Pacific Antibiotic Drugs Market: Segment Analysis
7.5 Asia-Pacific Antibiotic Drugs Market Segmentation: By Drug Class
7.5.1 Asia-Pacific Antibiotic Drugs Market, By Drug Class Overview
7.5.2 Asia-Pacific Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia-Pacific Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia-Pacific Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia-Pacific Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.6 Asia-Pacific Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific Antibiotic Drugs Market Segmentation: By Spectrum
7.6.1 Asia-Pacific Antibiotic Drugs Market, By Spectrum Overview
7.6.2 Asia-Pacific Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
7.6.3 Asia-Pacific Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
7.7 Asia-Pacific Antibiotic Drugs Market Segmentation: By Indication
7.7.1 Asia-Pacific Antibiotic Drugs Market, By Indication Overview
7.7.2 Asia-Pacific Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
7.7.3 Asia-Pacific Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
7.7.4 Asia-Pacific Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
7.7.5 Asia-Pacific Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
7.7.6 Asia-Pacific Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
7.8 Asia-Pacific Antibiotic Drugs Market Segmentation: By Country
7.8.1 China Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.8.1.1 China Antibiotic Drugs Market, By Drug Class
7.8.1.2 China Antibiotic Drugs Market, By Spectrum
7.8.1.3 China Antibiotic Drugs Market, By Indication
7.8.2 Japan Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.8.2.1 Japan Antibiotic Drugs Market, By Drug Class
7.8.2.2 Japan Antibiotic Drugs Market, By Spectrum
7.8.2.3 Japan Antibiotic Drugs Market, By Indication
7.8.2 India Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.8.2.1 India Antibiotic Drugs Market, By Drug Class
7.8.2.2 India Antibiotic Drugs Market, By Spectrum
7.8.2.3 India Antibiotic Drugs Market, By Indication
7.8.3 Rest of Asia-Pacific Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.8.3.1 Rest of Asia-Pacific Antibiotic Drugs Market, By Drug Class
7.8.3.2 Rest of Asia-Pacific Antibiotic Drugs Market, By Spectrum
7.8.3.3 Rest of Asia-Pacific Antibiotic Drugs Market, By Indication
8. Middle-East & Africa Antibiotic Drugs Market: Historic and Forecast (2019-2029)
8.1 Middle-East & Africa Antibiotic Drugs Market: Snapshot
8.2 Middle-East & Africa Antibiotic Drugs Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle-East & Africa Antibiotic Drugs Market: Key Factors
8.4 Middle-East & Africa Antibiotic Drugs Market: Segment Analysis
8.5 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Drug Class
8.5.1 Middle-East & Africa Antibiotic Drugs Market, By Drug Class Overview
8.5.2 Middle-East & Africa Antibiotic Drugs Market Size, By Cephalosporin, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle-East & Africa Antibiotic Drugs Market Size, By Penicillin, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle-East & Africa Antibiotic Drugs Market Size, By Macrolides, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Antibiotic Drugs Market Size, By Fluoroquinolone, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.6 Middle-East & Africa Antibiotic Drugs Market Size, By Other Drug Classes, By Value, 2019H-2029F (USD Billion & CAGR)
8.6 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Spectrum
8.6.1 Middle-East & Africa Antibiotic Drugs Market, By Spectrum Overview
8.6.2 Middle-East & Africa Antibiotic Drugs Market Size, By Broad Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
8.6.3 Middle-East & Africa Antibiotic Drugs Market Size, By Narrow Spectrum, By Value, 2019H-2029F (USD Billion & CAGR)
8.7 Middle-East & Africa Antibiotic Drugs Market Segmentation: By Indication
8.7.1 Middle-East & Africa Antibiotic Drugs Market, By Indication: Overview
8.7.2 Middle-East & Africa Antibiotic Drugs Market Size, By Pneumonia, By Value, 2019H-2029F (USD Billion & CAGR)
8.7.3 Middle-East & Africa Antibiotic Drugs Market Size, By Meningitis, By Value, 2019H-2029F (USD Billion & CAGR)
8.7.4 Middle-East & Africa Antibiotic Drugs Market Size, By Gastrointestinal infections, By Value, 2019H-2029F (USD Billion & CAGR)
8.7.5 Middle-East & Africa Antibiotic Drugs Market Size, By Urinary Tract Infections, By Value, 2019H-2029F (USD Billion & CAGR)
8.7.6 Middle-East & Africa Antibiotic Drugs Market Size, By Other Indications, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on the Global Antibiotic Drugs Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter's Five Forces Analysis
10.1 Porter's Five Forces Model
11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Antibiotic Drugs Market
11.4 Company Profiles
11.4.1 Abbott Laboratories
11.4.2 Johnson & Johnson
11.4.3 Pfizer
11.4.4 GSK PLC
11.4.5 Novartis AG
11.4.6 Roche Holding AG
11.4.7 Bayer AG
11.4.8 Merck & Co., Inc.
11.4.9 Viatris Inc.
11.4.10 Cipla